EPISODE · Jan 25, 2025 · 6 MIN
Part 2: 2024 Hatch-Waxman Year in Review
from Womble Perspectives · host Womble Bond Dickinson
Today, we're zooming in on key cases decided this past year and unpacking their broader implications for the pharmaceutical industry. We’ll look at decisions that refined safe harbor provisions, imposed stricter scrutiny on certain patents, tackled Orange Book listings, and much more. And before we close, we’ll share some insights into what the industry may encounter in 2025, so stick around to the end to hear what to expect in the coming year. Read the full article2024 Hatch-Waxman Year in ReviewAbout the authorsBen BourkeAlexander P. Wharton
What this episode covers
Today, we're zooming in on key cases decided this past year and unpacking their broader implications for the pharmaceutical industry. We’ll look at decisions that refined safe harbor provisions, imposed stricter scrutiny on certain patents, tackled Orange Book listings, and much more. And before we close, we’ll share some insights into what the industry may encounter in 2025, so stick around to the end to hear what to expect in the coming year. Read the full article 2024 Hatch-Wax...
NOW PLAYING
Part 2: 2024 Hatch-Waxman Year in Review
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m